Votes: MN HF284 | 2019-2020 | 91st Legislature

Bill Title: Insulin products sold in Minnesota cost review authorized by commissioner of health, excessive cost determined, maximum level of reimbursement established for insulin products if necessary, and money appropriated.

Spectrum: Partisan Bill (Democrat 15-0)

Status: (Introduced - Dead) 2019-04-01 - Author added Bierman [HF284 Detail]

Text: Latest bill text (Engrossed) [PDF]

Voting Records

ChamberVoteDateYeaNayNVAbsTotalResultSourceView
No roll call record information currently on file.
States not producing parsable votes may be available as images in Supplemental Documents.

Social Comments on MN HF284

feedback